• ქართული
  • English
  • GSK first-quarter beats estimates on shingles vaccine surge

    GlaxoSmithKline Plc reported better-than-expected first-quarter revenue and earnings on Wednesday, as sales of the British drugmaker’s fast-growing shingles vaccine surged another 60 percent.

    Market Quotes by TradingView